Overview

Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
French epidemiological data have shown a heterogeneous distribution of the risk of mortality from prostate cancer according to region. The main objective is to describe the distribution of prostate cancer stages when first line hormonal therapy is introduced (overall and by region).
Details
Lead Sponsor:
Ferring Pharmaceuticals
Treatments:
Deslorelin